Pyroptosis in combinatorial treatment to improve cancer patients' outcome, is that what we want?

被引：27
作者：
Pezuk, Julia Alejandra [1 ]
机构：
[1] Univ Anhanguera Sao Paulo UNIAN SP, Programa Posgrad Ensino Ciencias & Saude, Programa Posgrad Biotecnol & Inovacao Saude, Programa Mestrado Profiss Farm, Sao Paulo, Brazil
来源：
EBIOMEDICINE | 2019年 / 41卷
关键词：
KINASE; 1; POTENT;
D O I：
10.1016/j.ebiom.2019.03.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：17 / 18
页数：2
相关论文
共 10 条
[1]   Pyroptosis: host cell death and inflammation [J].
Bergsbaken, Tessa ;
Fink, Susan L. ;
Cookson, Brad T. .
NATURE REVIEWS MICROBIOLOGY, 2009, 7 (02) :99-109
[2]   In vitro targeting of Polo-like kinase 1 in bladder carcinoma: Comparative effects of four potent inhibitors [J].
Brassesco, Maria Sol ;
Pezuk, Julia Alejandra ;
Morales, Andressa Gois ;
de Oliveira, Jaqueline Carvalho ;
Roberto, Gabriela Molinari ;
da Silva, Glenda Nicioli ;
de Oliveira, Harley Francisco ;
Scrideli, Carlos Alberto ;
Tone, Luiz Gonzaga .
CANCER BIOLOGY & THERAPY, 2013, 14 (07) :648-657
[3]   Cancer-related inflammation and treatment effectiveness [J].
Diakos, Connie I. ;
Charles, Kellie A. ;
McMillan, Donald C. ;
Clarke, Stephen J. .
LANCET ONCOLOGY, 2014, 15 (11) :E493-E503
[4]   SynergyFinder: a web application for analyzing drug combination dose-response matrix data [J].
Ianevski, Aleksandr ;
He, Liye ;
Aittokallio, Tero ;
Tang, Jing .
BIOINFORMATICS, 2017, 33 (15) :2413-2415
[5]   Evaluation of Polo-like kinase 1 as a potential therapeutic target in Merkel cell carcinoma [J].
Kadletz, Lorenz ;
Bigenzahn, Johannes ;
Thurnher, Dietmar ;
Stanisz, Isabella ;
Erovic, Boban M. ;
Schneider, Sven ;
Schmid, Rainer ;
Seemann, Rudolf ;
Birner, Peter ;
Heiduschka, Gregor .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 :E1918-E1925
[6]   PLK-1: Angel or devil for cell cycle progression [J].
Kumar, Shiv ;
Sharma, Ashish Ranjan ;
Sharma, Garima ;
Chakraborty, Chiranjib ;
Kim, Jaebong .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2016, 1865 (02) :190-203
[7]   BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells [J].
Lian, Guodong ;
Li, Leping ;
Shi, Yulong ;
Jing, Changqing ;
Liu, Jinglei ;
Guo, Xiaobo ;
Zhang, Qingqing ;
Dai, Tianyu ;
Ye, Fei ;
Wang, Yanyan ;
Chen, Man .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (03) :804-814
[8]   Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling [J].
Min, Jee Sun ;
Bae, Soo Kyung .
ARCHIVES OF PHARMACAL RESEARCH, 2017, 40 (12) :1356-1379
[9]   Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells [J].
Pezuk, Julia Alejandra ;
Brassesco, Maria Sol ;
Manzini Ramos, Priscila Maria ;
Scrideli, Carlos Alberto ;
Tone, Luiz Gonzaga .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (09) :1278-1291
[10]  
Wu M., 2019, EBioMedicine
1